REGN-COV2 Antibody Cocktail
|Chemical Name||casirivimab and imdevimab|
|Dosage Form||Injection (intravenous; 120 mg/mL casirivimab/120 mg/mL imdevimab)|
|Drug Class||Monoclonal antibodies|
- For the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID19 and/or hospitalization.